FDA Inspection
S&B Pharma LLC DBA Norac PharmaS&B Pharma LLC DBA Norac Pharma – FDA Inspection, Sep 19, 2025
Record Details
This FDA Inspection record concerns S&B Pharma LLC DBA Norac Pharma, with an inspection on September 19, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 366ae64d-1efb-41ab-9ff5-117e78a65145
Inspection Facts
- Inspection number
- 1287536
- FDA center
- Human Drugs
Other FDA inspections of S&B Pharma LLC DBA Norac Pharma
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 10, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 10, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for S&B Pharma LLC DBA Norac Pharma
- FDA Inspection 1067410 - 2018-08-10
- FDA Inspection 928478 - 2015-05-22
- FDA Inspection 827719 - 2013-04-10
- FDA Inspection 759410 - 2011-12-02
- FDA Inspection 575623 - 2009-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.